SI-BONE Inc. (SIBN) Prices 3.19M Share Common Offering at $22/Sh

SI-BONE, Inc. (NASDAQ: SIBN), a Silicon Valley-based medical device company focused on the development of implantable devices used in the surgical treatment of the sacropelvic anatomy, today announced the pricing of its underwritten public offering of 3,190,053 shares of its common stock at a price to the public of $22.00 per share. Of the shares of common stock being offered, 3,000,000 shares are being offered by SI-BONE and 190,053 shares are being offered by a selling stockholder. Gross proceeds to SI-BONE from the offering are expected to be $66.0 million, before deducting underwriting discounts and commissions and estimated offering expenses. SI-BONE will not receive any proceeds from the sale of the shares of common stock by the selling stockholder in the offering. The offering is scheduled to close on October 19, 2020, subject to the satisfaction of customary closing conditions. In addition, SI-BONE has granted the underwriters a 30-day option to purchase up to an additional 478,507 shares of common stock on the same terms and conditions.

Morgan Stanley and BofA Securities are acting as joint book-running managers. Cantor Fitzgerald & Co., JMP Securities LLC and Needham & Company are acting as co-managers.

You May Also Be Interested In

• Western Union Co. (WU) PT Lowered to $8 at Cantor Fitzgerald
• Genco board reviews Diana Shipping's revised acquisition proposal
• Teledyne (TDY) PT Raised to $750 at Needham